Jan and AndrewIn early June, thousands of cancer experts, professionals and patients swarmed the McCormick Place Convention Center in Chicago for the 2018 American Society of Clinical Oncology (ASCO) annual meeting to discuss research discoveries and advances in care. The findings that were presented showcased promising innovations across oncology, such as further application of genetic testing for precision medicine, devising more effective treatment strategies, and concentrated efforts using “big data” to promote patient access to vital tools and resources. 

Patient Power founders, Andrew and Esther Schorr, attended ASCO to interview doctors and patient advocates from around the world on research and treatment developments. In the ever-evolving field of cancer research, characterized by many as a “fight” or “battle,” the expert interviews captured at the meeting deliver messages of growth and progress illustrated by the modern tools and cutting-edge strategies that help patients live longer, fuller lives with their condition. 

In the areas of breastlungprostateleukemia and myeloma, our conference coverage connects the patient community to newfound opportunities in cancer care and potentially life-changing research. Below are some key take-aways and links to the interviews from the meeting. 

Updates on genetic testing and precision medicine:

  • Dr. Nicholas Rohs discusses data presented for both small cell and non-small cell lung cancer, the swift momentum toward more personalized medicine and explains how understanding genetic mutational status has influenced treatment strategies.
  • Dr. Heather Cheng discusses what mutations indicate about risk and shares clinical results from the GENTLeMEN study, also known as a trial evaluating genetic testing for men with metastatic prostate cancer.
  • Advances in technology for multiple myeloma may help patients understand their disease course with less invasive techniques. Dr. James Berenson discusses the latest developments in biomarkers to evaluate change in clinical status.

Genetic links between cancers and cross-over therapies:

Re-evaluating and changing treatment strategies:

The role of technology and data in cancer care:

Staying up to date on developing research allows patients to make educated decisions about their care. Patient Power brings you conference coverage year-round, so join the community to stay informed about the latest oncology news as it happens.

~Amanda Beard

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.